Status:

UNKNOWN

Interaction Between HIV and Platelets

Lead Sponsor:

Assistance Publique - Hôpitaux de Paris

Collaborating Sponsors:

Institut National de la Santé Et de la Recherche Médicale, France

Conditions:

HIV Seropositivity

Eligibility:

All Genders

18+ years

Brief Summary

The investigators propose that the lack of immune response in InR is driven by HIV-containing platelets that might interact with macrophages and CD4+ T-cells although by different mechanisms. In the o...

Detailed Description

The investigators have recently shown that infectious HIV is carried by platelets in the blood of HIV-infected patients which failed to respond immunologically to cART despite viral suppression (Immun...

Eligibility Criteria

Inclusion

  • For all patients:
  • aged ⩾ 18 years;
  • patients who can read and understand information document.
  • For VIH positive patients without lymphoma:
  • VIH positive patients with negative or positive viral load under cART since 1 year;
  • patient under cART.
  • For VIH positive patients with lymphoma:
  • VIH positive patient with negative viral load under cART since 1 year;
  • patient with lymphoma.
  • For Healthy Volunteers:
  • VIH negative patient (control) already included in clinical trial;
  • patient major without haematological pathology.

Exclusion

  • patient \< 18 years;
  • Unable to read and understand information document.

Key Trial Info

Start Date :

April 17 2020

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

March 1 2025

Estimated Enrollment :

240 Patients enrolled

Trial Details

Trial ID

NCT04062825

Start Date

April 17 2020

End Date

March 1 2025

Last Update

March 17 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Service Hématologie Immunologie, Hôpital Ambroise Paré

Boulogne-Billancourt, France, 92100